Skip to content

Effects of Reverse Natural Apophyseal Glides as Compared to Ventro-cranial Translatoric Glides in the Management of Upper Thoracic Spine Hypomobility.

Effects of Reverse Natural Apophyseal Glides as Compared to Ventro-cranial Translatoric Glides in the Management of Upper Thoracic Spine Hypomobility.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07006402
Enrollment
48
Registered
2025-06-05
Start date
2024-07-18
Completion date
2025-06-20
Last updated
2025-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Thoracic Spine Hypomobility

Brief summary

This study is a randomized controlled trial and the purpose of the study is to determine the effects of reverse NAGs as compared to Ventro-cranial Translatoric Glides in upper thoracic spine hypomobility in terms of pain and range of motion.

Detailed description

OBJECTIVES: The objectives of this study are : 1. To determine the effects of reverse NAGs as compared to ventrocranial translatoric glide on UPPER BACK PAIN in upper thoracic spine hypomobility. 2. To determine the effects of reverse NAGs as compared to ventrocranial translatoric glide on THORACIC ROM in upper thoracic spine hypomobility. HYPOTHESIS: Alternate Hypothesis: 1. There will be a statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of upper back pain in persons with upper thoracic hypo mobility (p\<0.05). 2. There will be a statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of thoracic ROM in persons with upper thoracic hypo mobility (p\<0.05). NULL HYPOTHSIS : 1. There will be no statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of upper back pain in persons with upper thoracic hypo mobility (p\>0.05). 2. There will be no statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of thoracic ROM in persons with upper thoracic hypo mobility (p\>0.05). RESEARCH DESIGN : Experimental study .Randomized control trail.

Interventions

PROCEDUREReverse NAGS(experimental)

All participants will receive 2 weeks of intervention with a frequency of 3-4 days/week with a period of rest in between. 20 minutes of TENS+ hot pack will be given followed by Reverse NAGs on hypomobile segments at level T1-T4. In these type of mobilization, the inferior facet glides up on the superior. The mobilizations are repeated \<6 times and then movements are reassessed. If no change occurs, the process will be repeated upto 10 minutes with resting period.

PROCEDUREGrade III Ventro-Cranial Translatoric Glides(standard protocol)

All participants will receive 2 weeks of intervention with a frequency of 3-4 days/week with a period of rest in between. 20 minutes of TENS+ hot pack will be given followed by Grade III Ventro-Cranial Translatoric Glides on hypomobile segments at level T1-T4. The mobilization will be applied and sustained for 30-40 seconds and will be continued for 10-15 minutes in a cyclic manner. The grades of mobilization will be tapered as per individual needs.

Sponsors

Foundation University Islamabad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized Control Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* 1\. Both male and females 2. Adults (18-39 years) 3. Upper Thoracic hypomobility (flexion \<20° or extension \<25° or side bending \<20° or rotation \<35°)

Exclusion criteria

* 1-Ankylosing spondylitis 2-History of Spinal Fusion or spinal surgery (discectomy/laminectomy etc.) 3-Degenerative disc disorders 4-Cervical radiculopathy, Scoliosis 5-Spinal Stenosis or Myelopathy 6-Recent fracture or surgery 7-TB of spine, Spondylolisthesis 8-Not able to attend regular therapy appointments 9-Fibromyalgia/myofascial pain syndrome

Design outcomes

Primary

MeasureTime frameDescription
Thoracic PainVariable will be assessed at pre and post treatment for the total interval of 2 weeks.It will be measured using numeric pain rating scale (NPRS) in which the subjects select a number ranging from 0-10 according to their intensity of pain. '0' score indicates no pain while '10' indicates worst pain experienced.
Range of MotionVariable will be assessed at pre and post treatment for the total interval of 2 weeks.Range of motion will be measured using inclinometer. It will be used to measure range of motion of flexion, extension and lateral flexion on both right and left side on thoracic spine.

Countries

Pakistan

Contacts

Primary ContactAnam Shabbir, DPT
anamshabbir129@gmail.com+923305848103

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026